Demographic characteristics and neuropsychological assessments of subjective cognitive decline (SCD) (plus)
暂无分享,去创建一个
Ying Han | Jianguo Jia | Ying Han | Yun Li | Yu Sun | Y. Xing | Yu Sun | Yue Xing | Lixiao Hao | Yun Li | Jieyu Wang | Zichen Wang | Zhongying Zhang | Zhanyun Wei | Ge Gao | Lixiao Hao | Jianguo Jia | Zhanyun Wei | Jieyu Wang | Zichen Wang | Zhongying Zhang | Ge Gao
[1] B. Snitz,et al. Subjective memory complaints and concurrent memory performance in older patients of primary care providers , 2008, Journal of the International Neuropsychological Society.
[2] H. Charchat-Fichman,et al. Scoring systems for the Clock Drawing Test: A historical review , 2017, Dementia & neuropsychologia.
[3] Yingru Lv,et al. Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease , 2018, Neuropsychiatric disease and treatment.
[4] Clifford R Jack,et al. Testing the Right Target and Right Drug at the Right Stage , 2011, Science Translational Medicine.
[5] Q. Guo,et al. Prevalence, Risk Factors, and Complaints Screening Tool Exploration of Subjective Cognitive Decline in a Large Cohort of the Chinese Population. , 2017, Journal of Alzheimer's disease : JAD.
[6] Denise C. Park,et al. Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease , 2011, Alzheimer's & Dementia.
[7] Cynthia Rudin,et al. Learning classification models of cognitive conditions from subtle behaviors in the digital Clock Drawing Test , 2015, Machine Learning.
[8] Michael Wagner,et al. The characterisation of subjective cognitive decline , 2020, The Lancet Neurology.
[9] K. Morgan,et al. DEEP SEQUENCING ALZHEIMER'S DISEASE ASSOCIATED GENES, CLU, PICALM, CR1, ABCA7, BIN1, MS4A, CD2AP, EPHA1, AND CD33 IDENTIFIES POTENTIAL FUNCTIONAL SNPS , 2014, Alzheimer's & Dementia.
[10] S. Hemrungrojn,et al. The Montreal Cognitive Assessment—Basic: A Screening Tool for Mild Cognitive Impairment in Illiterate and Low‐Educated Elderly Adults , 2015, Journal of the American Geriatrics Society.
[11] J. Molinuevo,et al. The Subjective Cognitive Decline Questionnaire (SCD-Q): a validation study. , 2014, Journal of Alzheimer's disease : JAD.
[12] J Marshall,et al. Cerebral blood flow in dementia. , 1975, Archives of neurology.
[13] J. Morris. The Clinical Dementia Rating (CDR) , 1993, Neurology.
[14] F. Jessen,et al. Which features of subjective cognitive decline are related to amyloid pathology? Findings from the DELCODE study , 2019, Alzheimer's Research & Therapy.
[15] Jinkyun Park,et al. The clock drawing test as per pdf TI>: A systematic review and meta‐analysis of diagnostic accuracy as per pdf , 2018, Journal of advanced nursing.
[16] Andrew J. Saykin,et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease , 2014, Alzheimer's & Dementia.
[17] H. Brodaty,et al. ALZHEIMER'S DISEASE INTERNATIONAL , 1997, International journal of geriatric psychiatry.
[18] Z. Nasreddine,et al. Validation of the Chinese Version of Montreal Cognitive Assessment Basic for Screening Mild Cognitive Impairment , 2016, Journal of the American Geriatrics Society.
[19] K. Shulman,et al. IPA survey of brief cognitive screening instruments , 2006, International Psychogeriatrics.
[20] R. Mahendran,et al. Symptom clusters of subjective cognitive decline amongst cognitively normal older persons and their utilities in predicting objective cognitive performance: structural equation modelling , 2019, European journal of neurology.
[21] M. Hamilton,et al. Rating depressive patients. , 1980, The Journal of clinical psychiatry.
[22] Yingru Lv,et al. Short-Term Delayed Recall of Auditory Verbal Learning Test Is Equivalent to Long-Term Delayed Recall for Identifying Amnestic Mild Cognitive Impairment , 2012, PloS one.
[23] A. Alpérovitch,et al. Empirical evaluation of the ‘Cognitive Difficulties Scale’ for assessment of memory complaints in general practice: A study of 1628 cognitively normal subjects aged 45–75 years , 1993 .
[24] Mohamed A. Khalil,et al. Validation of Montreal Cognitive Assessment-Basic in a sample of elderly Egyptians with neurocognitive disorders , 2019, Aging & mental health.
[25] Lijun Wang,et al. Gender Differences in Elderly With Subjective Cognitive Decline , 2018, Front. Aging Neurosci..
[26] K. Shulman,et al. The Times They Are a-Changin’ , 2015, Journal of geriatric psychiatry and neurology.
[27] F. Maestú,et al. Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories. , 2018, Journal of Alzheimer's disease : JAD.
[28] Andrew J. Saykin,et al. Implementation of subjective cognitive decline criteria in research studies , 2017, Alzheimer's & Dementia.
[29] W. M. van der Flier,et al. Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies. , 2015, Journal of Alzheimer's disease : JAD.
[30] Ying Han,et al. Risk Factors and Neuropsychological Assessments of Subjective Cognitive Decline (plus) in Chinese Memory Clinic , 2019, Front. Neurosci..
[31] J. Molinuevo,et al. Brain and cognitive correlates of subjective cognitive decline-plus features in a population-based cohort , 2018, Alzheimer's Research & Therapy.
[32] Sandra Weintraub,et al. Objective features of subjective cognitive decline in a United States national database , 2017, Alzheimer's & Dementia.
[33] D. Moser,et al. Awareness of memory deficits in subjective cognitive decline, mild cognitive impairment, Alzheimer's disease and Parkinson's disease , 2014, International Psychogeriatrics.
[34] W. M. van der Flier,et al. Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results , 2018, Alzheimer's Research & Therapy.
[35] Qihao Guo,et al. The Shape Trail Test: Application of a New Variant of the Trail Making Test , 2013, PloS one.
[36] F. Maestú,et al. Specific Features of Subjective Cognitive Decline Predict Faster Conversion to Mild Cognitive Impairment. , 2016, Journal of Alzheimer's disease : JAD.
[37] M. Horhota,et al. Examining the relationship between subjective and objective memory performance in older adults: a meta-analysis. , 2014, Psychology and aging.
[38] Q. Guo,et al. A study of validity of a new scoring system of clock drawing test , 2008 .
[39] Q. Guo,et al. Clustering and switching during a semantic verbal fluency test contribute to differential diagnosis of cognitive impairment , 2013, Neuroscience Bulletin.
[40] Richard N. Jones,et al. Development of a subjective cognitive decline questionnaire using item response theory: A pilot study , 2015, Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring.
[41] W. Maier,et al. Subjective Cognitive Decline May Be a Stronger Predictor of Incident Dementia in Women than in Men. , 2019, Journal of Alzheimer's disease : JAD.
[42] A. Hida,et al. Effects of Demographic Variables on Subjective Neurocognitive Complaints Using the Neurocognitive Questionnaire (NCQ) in an Aged Japanese Population , 2019, International journal of environmental research and public health.
[43] Li Wang,et al. Subjective Memory Deterioration and Future Dementia in People Aged 65 and Older , 2004, Journal of the American Geriatrics Society.
[44] A. Villringer,et al. Memory-related subjective cognitive symptoms in the adult population: prevalence and associated factors – results of the LIFE-Adult-Study , 2018, BMC Psychology.
[45] M. Yassuda,et al. A subtest analysis of the Montreal cognitive assessment (MoCA): which subtests can best discriminate between healthy controls, mild cognitive impairment and Alzheimer's disease? , 2015, International Psychogeriatrics.
[46] David R. Roalf,et al. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging , 2013, Alzheimer's & Dementia.
[47] K. Shulman. Clock‐drawing: is it the ideal cognitive screening test? , 2000, International journal of geriatric psychiatry.
[48] Lv Chuan-zhen,et al. Norm of Auditory Verbal Learning Test in the Normal Aged in China Community , 2007 .
[49] E. Siemers,et al. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. , 2014, The New England journal of medicine.
[50] A. Saykin,et al. Memory concerns in the early Alzheimer's disease prodrome: Regional association with tau deposition , 2018, Alzheimer's & dementia.